Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2

被引:201
作者
Kawaguchi, Takumi [1 ]
Ide, Tatsuya [1 ]
Taniguchi, Eitaro [1 ]
Hirano, Eiichi [1 ]
Itou, Minoru [1 ]
Sumie, Shuji [1 ]
Nagao, Yumiko [1 ]
Yanagimoto, Chikatoshi [1 ]
Hanada, Shinichiro [1 ]
Koga, Hironori [1 ]
Sata, Michio [1 ]
机构
[1] Kurume Univ, Sch Med, Dept Med, Div Gastroenterol,Dept Digest Dis Informat & Res, Kurume, Fukuoka 8300011, Japan
关键词
D O I
10.1111/j.1572-0241.2006.01038.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: Hepatitis C virus (HCV) infection is linked to greater insulin resistance. Although HCV itself is a candidate for the development of insulin resistance, the effects of antiviral treatment on impaired glucose metabolism remain unclear. The aim of this study is to examine the effects of clearance of HCV on insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate (IRS)1/2, central molecules for insulin signaling. METHODS: We analyzed 89 biopsy-proven patients with chronic HCV infection. Patients received interferon-alpha or interferon-alpha plus ribavirin for 6 months and were classified into three groups at 6 months after the conclusion of antiviral therapy according to their response to antiviral therapy: sustained responders (N = 29), relapsers (N = 12), and nonresponders (N = 48). Insulin resistance and beta-cell function were assessed by the homeostasis model assessment method (HOMA-IR and HOMA-%B, respectively). Hepatic expression of IRS1/2 was evaluated by immunoblotting and immunostaining in 14 sustained responders. RESULTS: In nonresponders and relapsers, there were no significant changes in HOMA-IR and HOMA-%B values after antiviral therapy. On the other hand, in sustained responders, HOMA-IR values significantly decreased to 1.7 +/- 0.8 from 3.1 +/- 1.1 (P < 0.05) after antiviral therapy. Similarly, HOMA-%B values significantly decreased to 90.6 +/- 10.0 from 113.7 +/- 15.3 (P < 0.05). Immunoblotting showed a threefold increase in IRS1/2 expression after clearance of HCV. Immunostaining revealed that greater IRS1/2 expression was seen in hepatocytes. CONCLUSIONS: We showed that clearance of HCV improves insulin resistance, beta-cell function, and hepatic IRS1/2 expression.
引用
收藏
页码:570 / 576
页数:7
相关论文
共 34 条
[1]   Excess risk of primary liver cancer in patients with diabetes mellitus [J].
Adami, HO ;
Chow, WH ;
Nyren, O ;
Berne, C ;
Linet, MS ;
Ekbom, A ;
Wolk, A ;
McLaughlin, JK ;
Fraumeni, JF .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (20) :1472-1477
[2]   Post-liver transplantation diabetes mellitus: An association with hepatitis C [J].
AlDosary, AA ;
Ramji, AS ;
Elliott, TG ;
Sirrs, SM ;
Thompson, DM ;
Erb, SR ;
Steinbrecher, UP ;
Yoshida, EM .
LIVER TRANSPLANTATION, 2002, 8 (04) :356-361
[3]   EVIDENCE FOR A LINK BETWEEN HEPATITIS-C VIRUS-INFECTION AND DIABETES-MELLITUS IN A CIRRHOTIC POPULATION [J].
ALLISON, MED ;
WREGHITT, T ;
PALMER, CR ;
ALEXANDER, GJM .
JOURNAL OF HEPATOLOGY, 1994, 21 (06) :1135-1139
[4]   Association of diabetes and hepatitis C infection: Epidemiologic evidence and pathophysiologic insights [J].
Bahtiyar G. ;
Shin J.J. ;
Aytaman A. ;
Sowers J.R. ;
McFarlane S.I. .
Current Diabetes Reports, 2004, 4 (3) :194-198
[5]   An algorithm for the grading of activity in chronic hepatitis C [J].
Bedossa, P ;
Poynard, T .
HEPATOLOGY, 1996, 24 (02) :289-293
[6]   EXCESSIVE SERUM INSULIN RESPONSE TO ORAL GLUCOSE IN OBESITY AND MILD DIABETES - STUDY OF 501 PATIENTS [J].
CHILES, R ;
TZAGOURNIS, M .
DIABETES, 1970, 19 (06) :458-+
[7]   Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma [J].
El-Serag, HB ;
Tran, T ;
Everhart, JE .
GASTROENTEROLOGY, 2004, 126 (02) :460-468
[8]   Insulin resistance/β-cell function and serum ferritin level in non-diabetic patients with hepatitis C virus infection [J].
Furutani, M ;
Nakashima, T ;
Sumida, Y ;
Hirohama, A ;
Yoh, T ;
Kakisaka, Y ;
Mitsuyoshi, H ;
Senmaru, H ;
Okanoue, T .
LIVER INTERNATIONAL, 2003, 23 (04) :294-299
[9]   In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy [J].
Hickman, IJ ;
Powell, EE ;
Prins, JB ;
Clouston, AD ;
Ash, S ;
Purdie, DM ;
Jonsson, JR .
JOURNAL OF HEPATOLOGY, 2003, 39 (06) :1042-1048
[10]   Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression [J].
Hui, JM ;
Sud, A ;
Farrell, GC ;
Bandara, P ;
Byth, K ;
Kench, JG ;
McCaughan, GW ;
George, J .
GASTROENTEROLOGY, 2003, 125 (06) :1695-1704